Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/jspui/handle/10553/153719
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Clavo Varas, Bernardino | en_US |
| dc.contributor.author | Cordoba-Lanus, Elizabeth | en_US |
| dc.contributor.author | Martinez-Sanchez, Gregorio | en_US |
| dc.contributor.author | Federico, Mario | en_US |
| dc.contributor.author | Canovas-Molina, Angeles | en_US |
| dc.contributor.author | Pinero, Jose E. | en_US |
| dc.contributor.author | Vargas-Prado, Ana M. | en_US |
| dc.contributor.author | Ramchandani, Avinash | en_US |
| dc.contributor.author | Zajac, Marta | en_US |
| dc.contributor.author | Ribeiro, Ivone | en_US |
| dc.contributor.author | Navarro, Minerva | en_US |
| dc.contributor.author | Jorge, Ignacio J. | en_US |
| dc.contributor.author | Gonzalez-Martin, Jesus M. | en_US |
| dc.contributor.author | Martin-Alfaro, Ruth | en_US |
| dc.contributor.author | Fernandez-Tagarro, Maria | en_US |
| dc.contributor.author | Diaz-Garrido, Juan A. | en_US |
| dc.contributor.author | Lorenzo-Morales, Jacob | en_US |
| dc.contributor.author | Rodríguez Esparragón, Francisco Javier | en_US |
| dc.date.accessioned | 2025-12-16T16:49:05Z | - |
| dc.date.available | 2025-12-16T16:49:05Z | - |
| dc.date.issued | 2025 | en_US |
| dc.identifier.issn | 2077-0383 | en_US |
| dc.identifier.other | WoS | - |
| dc.identifier.uri | https://accedacris.ulpgc.es/jspui/handle/10553/153719 | - |
| dc.description.abstract | Background: Chronic pelvic toxicity induced by radiotherapy and/or chemotherapy (R/CIPT) is a debilitating sequela in gynecological cancer survivors, often refractory to conventional treatments and potentially linked to gut microbiota dysbiosis. Ozone therapy (OT), particularly rectal insufflation, demonstrates anti-inflammatory and redox-modulating effects through hormetic mechanisms (Nrf2 activation/NF-kappa B inhibition). We hypothesize that its clinical benefit is mediated, in part, by restoring gut microbial homeostasis. Objective: This manuscript proposes a clinical study to evaluate the impact of rectal OT on the gut microbiota of patients with gynecological cancers and chronic R/CIPT. Proposed Methods: A prospective, observational study of 38 patients is outlined: 19 with CTCAE v5.0 Grade >= 2 chronic R/CIPT receiving compassionate rectal OT (similar to 40 sessions over 4 months), and 19 matched controls without toxicity. Stool samples for 16S rRNA sequencing will be collected from the OT group pre- and post-intervention and once from controls. Primary endpoints are changes in microbiota composition/diversity and pelvic toxicity scores (CTCAE v5.0, EORTC QLQ-CX24). Secondary endpoints include quality of life (EORTC QLQ-C30, EQ-5D-5L), anxiety/depression (HADS), and serum inflammatory/oxidative stress biomarker analysis. Anticipated Results and Conclusion: This will be the first study to prospectively investigate whether rectal OT's effect correlates with a beneficial shift in the gut microbiota, specifically an increase in commensals (e.g., short-chain fatty acids producers) and a decrease in pathobionts. If successful, OT could be assessed as a novel, microbiota-targeting intervention for R/CIPT. The findings from this pilot study will provide the necessary groundwork for a future randomized controlled trial to definitively establish causality and efficacy. | en_US |
| dc.language | eng | en_US |
| dc.relation.ispartof | Journal of Clinical Medicine | en_US |
| dc.source | Journal Of Clinical Medicine [eISSN 2077-0383] ,v. 14 (22), (Noviembre 2025) | en_US |
| dc.subject | 32 Ciencias médicas | en_US |
| dc.subject | 3201 Ciencias clínicas | en_US |
| dc.subject | 320713 Oncología | en_US |
| dc.subject | 320108 Ginecología | en_US |
| dc.subject | 320112 Radioterapia | en_US |
| dc.subject | 320806 Quimioterapia | en_US |
| dc.subject.other | Chemotherapy | en_US |
| dc.subject.other | Therapy | en_US |
| dc.subject.other | Ozone Therapy | en_US |
| dc.subject.other | Gut Microbiota | en_US |
| dc.subject.other | Gynecological Cancer | en_US |
| dc.subject.other | Radiotherapy Toxicity | en_US |
| dc.subject.other | Chemotherapy Toxicity | en_US |
| dc.subject.other | Dysbiosis | en_US |
| dc.subject.other | Supportive Care | en_US |
| dc.title | Modulating the Gut Microbiota via Rectal Ozone Insufflation in Gynecological Cancer Patients with Radiotherapy/Chemotherapy-Induced Pelvic Toxicity: A Proposed Clinical Study Protocol | en_US |
| dc.type | info:eu-repo/semantics/Article | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.3390/jcm14228015 | en_US |
| dc.identifier.isi | 001625668000001 | - |
| dc.identifier.eissn | 2077-0383 | - |
| dc.identifier.issue | 22 | - |
| dc.relation.volume | 14 | en_US |
| dc.investigacion | Ciencias de la Salud | en_US |
| dc.type2 | Artículo | en_US |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.description.numberofpages | 15 | en_US |
| dc.utils.revision | Sí | en_US |
| dc.contributor.wosstandard | WOS:Clavo, B | - |
| dc.contributor.wosstandard | WOS:Cordoba-Lanús, E | - |
| dc.contributor.wosstandard | WOS:Martínez-Sánchez, G | - |
| dc.contributor.wosstandard | WOS:Federico, M | - |
| dc.contributor.wosstandard | WOS:Cánovas-Molina, A | - |
| dc.contributor.wosstandard | WOS:Piñero, JE | - |
| dc.contributor.wosstandard | WOS:Vargas-Prado, AM | - |
| dc.contributor.wosstandard | WOS:Ramchandani, A | - |
| dc.contributor.wosstandard | WOS:Zajac, M | - |
| dc.contributor.wosstandard | WOS:Ribeiro, I | - |
| dc.contributor.wosstandard | WOS:Navarro, M | - |
| dc.contributor.wosstandard | WOS:Jorge, IJ | - |
| dc.contributor.wosstandard | WOS:González-Martín, JM | - |
| dc.contributor.wosstandard | WOS:Martín-Alfaro, R | - |
| dc.contributor.wosstandard | WOS:Fernández-Tagarro, M | - |
| dc.contributor.wosstandard | WOS:Díaz-Garrido, JA | - |
| dc.contributor.wosstandard | WOS:Lorenzo-Morales, J | - |
| dc.contributor.wosstandard | WOS:Rodríguez-Esparragon, F | - |
| dc.date.coverdate | Noviembre 2025 | en_US |
| dc.identifier.ulpgc | Sí | en_US |
| dc.contributor.buulpgc | BU-MED | en_US |
| dc.description.sjr | 0,919 | |
| dc.description.jcr | 2,9 | |
| dc.description.sjrq | Q1 | |
| dc.description.jcrq | Q1 | |
| dc.description.scie | SCIE | |
| dc.description.miaricds | 10,5 | |
| item.grantfulltext | open | - |
| item.fulltext | Con texto completo | - |
| crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
| crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
| crisitem.author.dept | GIR IUSA-ONEHEALTH 5: Reproducción Animal, Oncología y Anestesiología Comparadas | - |
| crisitem.author.dept | IU de Sanidad Animal y Seguridad Alimentaria | - |
| crisitem.author.orcid | 0000-0003-2522-1064 | - |
| crisitem.author.orcid | 0000-0003-1663-3673 | - |
| crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
| crisitem.author.parentorg | IU de Sanidad Animal y Seguridad Alimentaria | - |
| crisitem.author.fullName | Clavo Varas, Bernardino | - |
| crisitem.author.fullName | Rodríguez Esparragón, Francisco Javier | - |
| Appears in Collections: | Artículos | |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.